Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic chronic HCV non cirrhotic treatment-na ïve Egyptian patients eradicated with sofosbuvir plus daclatasvir.
CONCLUSION: This study supports the idea that HCV eradication leads to a reduction in HbA1c in patients with diabetes, which could delay the onset and progression of microvascular diabetes complications.
PMID: 31146663 [PubMed - as supplied by publisher]
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Hussein HA, Allam AS, Moaty ASA Tags: Curr Diabetes Rev Source Type: research
More News: Bilirubin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Egypt Health | Endocrinology | Hepatitis | Hepatitis C | Insulin | Liver | Metabolic Syndrome | Statistics | Study | Urology & Nephrology | Virology